BEVERLY, Mass., Aug. 10, 2017 -- IXYS Integrated Circuits Division (ICD), Inc., a wholly owned subsidiary of IXYS Corporation (NASDAQ:IXYS), announced the immediate production release of the CPC1511, a current limiting 1-Form-A normally open Solid State Relay (SSR) that replaces electromechanical devices while enhancing the performance of switching applications.
The 230V CPC1511 is manufactured with an optically isolated control input, and an integrated monolithic die for the output current. Fabricated with ICD’s HVIC SOI technology, the device is an integrated powered driver with active current limiting and thermal shutdown circuitry and Power MOSFET switches. CPC1511 incorporates thermal shutdown circuitry for improved survivability in harsh environments and is designed to pass regulatory voltage surge requirements when provided with appropriate over voltage protection circuitry. This device is designed specifically for harsh AC or DC applications where printed circuit board space is at a premium and additional power supplies are not available. The active current limit and thermal shutdown features offer automatic recovery to the appropriate switch state, as determined by the input control current, once the fault condition is removed. This fault protection circuitry provides excellent robustness in high stress switching environments.
The CPC1511 relay provides current limiting for unidirectional DC applications, in addition to typical AC applications. This current limiting 1-Form-A normally open SSR is ideal for general power switching applications in instrumentation, IoT products, industrial controls, peripherals, security, and medical equipment. Key features include built-in current-limiting protection circuitry, thermal shutdown, linear AC/DC operation, low power consumption, clean, bounce-free switching, and an extended operational lifetime over electromechanical relays .
The CPC1511 is available in a 4-Pin Power SIP Package (25/Tube). For more information and to access the datasheet, visit: http://www.ixysic.com/home/pages.nsf/locate.rep, and http://www.ixysic.com/home/pdfs.nsf/www/CPC1511.pdf/$file/CPC1511.pdf
About IXYS ICD and IXYS Corporation
IXYS Integrated Circuits Division (ICD), a leader in the design and manufacture of solid state relays and high voltage integrated circuits, is a wholly owned subsidiary of IXYS Corporation. IXYS Corporation develops and markets primarily high performance power semiconductor devices that are used in controlling and converting electrical power efficiently in power systems for the telecommunication and internet infrastructure, motor drives, medical systems and transportation. IXYS also serves its markets with a combination of digital and analog integrated circuits, power systems and RF GaAs and GaN based products. Additional information about IXYS Integrated Circuits Division, Zilog and IXYS may be found at www.ixysic.com, www.zilog.com and www.ixys.com.
Safe Harbor Statement
Any statements contained in this press release that are not statements of historical fact, including the performance, rating, survivability, applications, availability and operation of products for various applications, may be deemed to be forward-looking statements. There are a number of important factors that could cause the results of IXYS to differ materially from those indicated by these forward-looking statements, including, among others, risks detailed from time to time in the Company's SEC reports, including its Form 10-Q for the fiscal quarter ended June 30, 2017. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements.
Contact: Catherine Austin Ph: 978-524-6823 Fax: 978-524-4900


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



